• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ACR 2.17% 4.5¢

ACRUX LIMITED - Charts / Financials

Acrux Limited is an Australia-based specialty pharmaceutical company. The Company is... Acrux Limited is an Australia-based specialty pharmaceutical company. The Company is engaged in developing and commercializing a pipeline of topically applied pharmaceutical products. Its products include Lidocaine and Prilocaine Cream, USP 2.5%/2.5%, Lenzetto, Evamist, Dapsone Gel, 5% and Testosterone Topical Solution, 30 mg / 1.5 ml. Lidocaine and Prilocaine Cream USP (a eutectic mixture of lidocaine 2.5% and prilocaine 2.5%) is indicated as a topical anesthetic for use on normal intact skin for local analgesia and genital mucous membranes for superficial minor surgery and as pretreatment for infiltration anesthesia. Lenzetto (estradiol 1.53 mg/spray, transdermal spray, solution) is an estradiol spray for women which is used to treat moderate to severe hot flushes commonly associated with menopause. Testosterone Topical Solution is indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

refresh Created with Sketch. REFRESH
Last update - 16.20pm 22/11/2024 (20 minute delay) ?
Day
Open 4.5¢   Day High 4.5¢   Day Low 4.5¢
Daily Volume 25000
Bids   Sellers
Number Price Volume   Number Price Volume
2 4.4¢ 45453   1 4.6¢ 51547

Directors & Senior Management

Mr. Michael John Kotsanis Chief Executive Officer, Managing Director, Executive Director
Ms. Joanna Johnson Chief Financial Officer, Company Secretary
Ms. Felicia Colagrande Product Development and Technical Affairs Director
Mr. Mark Hyman Project and Technical Development Director
Mr. Ross Dobinson Independent Non-Executive Chairman of the Board
Dr. Geoffrey E. D. Brooke Independent Non-Executive Director
Mr. Don Brumley Independent Non-Executive Director
Dr. Timothy Charles Oldham Independent Non-Executive Director

Data source: Refinitiv

(20min delay)
Last
4.5¢
Change
-0.001(2.17%)
Mkt cap ! $15.69M
Open High Low Value Volume
4.5¢ 4.5¢ 4.5¢ $1.125K 25K

Buyers (Bids)

No. Vol. Price($)
2 45453 4.4¢
 

Sellers (Offers)

Price($) Vol. No.
4.6¢ 51547 1
View Market Depth
Last trade - 15.49pm 22/11/2024 (20 minute delay) ?
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.